Our Team
Hyeon Kim, PhD
Christopher Kabrhel, MD, MPH
Richard N. Channick, MD
Founder & CEO
25+ years of biotech leadership with a track record of advancing therapeutics to IND, including two First-in-Human IND approvals. Inventor on 70+ patents and recipient of the 2026 Amgen Golden Ticket Award.
Richard N. Channick, MD
Christopher Kabrhel, MD, MPH
Richard N. Channick, MD
Scientific Advisory Board Member
Professor and Endowed Chair in Pulmonary Arterial Hypertension at the David Geffen School of Medicine. 25+ years of experience in pulmonary vascular disease and contributor to multiple FDA-approved therapies.
Christopher Kabrhel, MD, MPH
Christopher Kabrhel, MD, MPH
Christopher Kabrhel, MD, MPH
Scientific Advisory Board Member
Professor at Harvard Medical School and emergency physician at Massachusetts General Hospital. Internationally recognized expert in pulmonary embolism with 230+ publications.
Jason Hinman, MD, PhD
Christopher Kabrhel, MD, MPH
Christopher Kabrhel, MD, MPH
Scientific Advisory Board Member
Professor of Neurology at UCLA's David Geffen School of Medicine and Director of the Center for Alzheimer's Research and Care at UCLA. Expert in cerebrovascular disease and translational neuroscience.